tiprankstipranks
Advertisement
Advertisement

OM Stock Latest News

Outset Medical Announces Executive Vice President Marc Nash Departure
Company AnnouncementsOutset Medical Announces Executive Vice President Marc Nash Departure
5d ago
8K
OM
Outset Medical Bets on Margin Gains and Next-Gen Tableau
PremiumCompany Announcements
Outset Medical Bets on Margin Gains and Next-Gen Tableau
26d ago
OM
Outset Medical price target lowered to $10 from $12 at TD Cowen
PremiumThe Fly
Outset Medical price target lowered to $10 from $12 at TD Cowen
26d ago
OM
Outset Medical price target lowered to $6 from $8 at Stifel
PremiumThe Fly
Outset Medical price target lowered to $6 from $8 at Stifel
26d ago
OM
Outset Medical reports Q1 EPS ($1.03), consensus (79c)
PremiumThe Fly
Outset Medical reports Q1 EPS ($1.03), consensus (79c)
27d ago
OM
Outset Medical backs FY26 revenue view $125M-$130M, consensus $126.77M
PremiumThe FlyOutset Medical backs FY26 revenue view $125M-$130M, consensus $126.77M
27d ago
OM
AI Models Turn Cautiously More Positive on Outset Medical as Turnaround Takes Shape
Premium
AI Analyst Ratings
AI Models Turn Cautiously More Positive on Outset Medical as Turnaround Takes Shape
2M ago
OM
Outset Medical: Tablo Platform’s System‑Wide Insights Drive Strategic Health System Adoption and Support Buy Rating
Premium
Ratings
Outset Medical: Tablo Platform’s System‑Wide Insights Drive Strategic Health System Adoption and Support Buy Rating
3M ago
OM
Outset Medical Earnings Call Highlights Margin Turnaround
PremiumCompany Announcements
Outset Medical Earnings Call Highlights Margin Turnaround
4M ago
OM
Outset Medical price target lowered to $12 from $15 at TD Cowen
PremiumThe Fly
Outset Medical price target lowered to $12 from $15 at TD Cowen
4M ago
OM
Outset Medical price target lowered to $15 from $17 at BTIG
PremiumThe Fly
Outset Medical price target lowered to $15 from $17 at BTIG
4M ago
OM
Outset Medical: Improving Visibility, Stronger Margins, and Next-Gen Tablo Support Buy Rating and $15 Target
PremiumRatings
Outset Medical: Improving Visibility, Stronger Margins, and Next-Gen Tablo Support Buy Rating and $15 Target
4M ago
OM
Outset Medical: Stabilizing Execution, Improving Margins, and Balanced 2026 Outlook Support Buy Rating Despite Lower Target
PremiumRatingsOutset Medical: Stabilizing Execution, Improving Margins, and Balanced 2026 Outlook Support Buy Rating Despite Lower Target
4M ago
OM
Outset Medical reports Q4 EPS ($1.09), consensus (68c)
Premium
The Fly
Outset Medical reports Q4 EPS ($1.09), consensus (68c)
4M ago
OM
Outset Medical sees FY26 revenue $125M-$130M, consensus $127.64M
Premium
The Fly
Outset Medical sees FY26 revenue $125M-$130M, consensus $127.64M
4M ago
OM
OM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
OM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
OM
Outset Medical Wins FDA Clearance for Next-Gen Tablo System
PremiumCompany Announcements
Outset Medical Wins FDA Clearance for Next-Gen Tablo System
4M ago
8K
OM
Outset Medical says next-generation Tablo platform receives FDA clearance
PremiumThe Fly
Outset Medical says next-generation Tablo platform receives FDA clearance
4M ago
OM
Outset Medical Previews 2025 Results and Adds Director
PremiumCompany Announcements
Outset Medical Previews 2025 Results and Adds Director
5M ago
8K
OM
Outset Medical reports Q4 revenue $28.9M, consensus $26.15M
PremiumThe FlyOutset Medical reports Q4 revenue $28.9M, consensus $26.15M
5M ago
OM
Outset Medical appoints Prange to its board of directors
Premium
The Fly
Outset Medical appoints Prange to its board of directors
5M ago
OM
ATRC
Outset Medical price target lowered to $8 from $14 at Stifel
Premium
The Fly
Outset Medical price target lowered to $8 from $14 at Stifel
5M ago
OM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >